Cipher Pharmaceuticals Inc. Cut to Hold From Buy by Stifel Nicolaus

Cipher Pharmaceuticals Inc. Cut to Hold From Buy by Stifel Nicolaus

Dow JonesMay 14 00:17

Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50

Stifel GMP on Monday downgraded its rating on the shares of Cipher Pharmaceuticals (CPH.TO) to hold from buy even as it raised its price target to C$9.50 from C$8.00 following a rise in the company's

MT NewswiresMay 13 21:43

Earnings Call Summary | Cipher Pharmaceuticals Inc(CPHRF.US) Q1 2024 Earnings Conference

The following is a summary of the Cipher Pharmaceuticals Inc. (CPHRF) Q1 2024 Earnings Call Transcript:Financial Performance:Cipher reported a total net revenue for Q1 2024 of $5.9 million, a 20% incr

Futu NewsMay 11 03:30 · Conference Call

Press Release: Cipher Pharmaceuticals Reports First Quarter 2024 Results

Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire MISSISSAUGA, ON, May 9, 2024 (All figures are presented in U.S. Dollars) -- Adjusted EBITDA in Q1 2024 was $3.6 million

Dow JonesMay 10 05:00

Stocks in Play: Cipher Pharmaceuticals Inc.

Baystreet.caMay 3 22:26

Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call

Stockhouse May 3 19:05